Terug
67
Dagbereik
€ 72,92
€ 74,43
52-Weeksbereik
€ 56,71
€ 99,50
Volume
216.023
50D / 200D Gem.
€ 78,57
/
€ 80,76
Vorige Slotkoers
€ 73,92
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 21,0 | 0,3 |
| P/B | 3,0 | 2,9 |
| ROE % | 16,2 | 3,7 |
| Net Margin % | 8,9 | 3,8 |
| Rev Growth 5Y % | 42,2 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 107,00
+46.0%
Low: € 90,00
High: € 124,00
Forward K/W
8,2
Forward WPA
€ 9,05
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,1 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 13,45
€ 12,71 – € 13,95
|
1,5 B | 2 |
| FY2029 |
€ 12,69
€ 11,99 – € 13,16
|
1,4 B | 2 |
| FY2028 |
€ 12,46
€ 11,78 – € 12,92
|
1,3 B | 3 |
Belangrijkste Punten
Revenue grew 42,18% annually over 5 years — strong growth
ROE of 16,16% — decent returns on equity
Generating 171,39M in free cash flow
Cash machine — converts 218,79% of earnings into free cash flow
Capital efficient — spends only 1,57% of revenue on capex
Groei
Revenue Growth (5Y)
42,18%
Revenue (1Y)43,78%
Earnings (1Y)N/A
FCF Growth (3Y)30,62%
Kwaliteit
Return on Equity
16,16%
ROIC7,04%
Net Margin8,87%
Op. Margin9,20%
Veiligheid
Debt / Equity
0,60
Current Ratio2,71
Interest Coverage4,05
Waardering
P/E Ratio
21,02
P/B Ratio3,04
EV/EBITDA20,76
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 43,78% | Revenue Growth (3Y) | 34,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 104,24% |
| Revenue Growth (5Y) | 42,18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 883,37M | Net Income (TTM) | 78,34M |
| ROE | 16,16% | ROA | 5,44% |
| Gross Margin | 51,01% | Operating Margin | 9,20% |
| Net Margin | 8,87% | Free Cash Flow (TTM) | 171,39M |
| ROIC | 7,04% | FCF Growth (3Y) | 30,62% |
| Safety | |||
| Debt / Equity | 0,60 | Current Ratio | 2,71 |
| Interest Coverage | 4,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 21,02 | P/B Ratio | 3,04 |
| P/S Ratio | 1,86 | PEG Ratio | -0,05 |
| EV/EBITDA | 20,76 | Dividend Yield | 0,00% |
| Market Cap | 1,65B | Enterprise Value | 1,69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 883,37M | 614,38M | 486,82M | 316,39M | 216,14M |
| Net Income | 78,34M | -18,52M | 18,78M | -47,90M | -42,60M |
| EPS (Diluted) | 3,32 | -1,04 | 0,94 | -3,05 | -3,40 |
| Gross Profit | 450,64M | 364,17M | 305,30M | 177,60M | 115,53M |
| Operating Income | 81,23M | 584.000,0 | 46,97M | -35,28M | -39,79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,44B | 1,28B | 904,42M | 760,09M | 771,60M |
| Total Liabilities | 899,65M | 855,17M | 446,82M | 421,55M | 412,86M |
| Shareholders' Equity | 540,72M | 428,53M | 457,60M | 338,54M | 358,74M |
| Total Debt | 325,20M | 624,09M | 285,67M | 286,52M | 287,37M |
| Cash & Equivalents | 285,59M | 144,86M | 221,12M | 48,23M | 100,30M |
| Current Assets | 753,12M | 527,68M | 519,82M | 344,26M | 321,78M |
| Current Liabilities | 278,11M | 193,68M | 145,48M | 99,44M | 87,54M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#124 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026